share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Gibbs Michael Terrence

SEC announcement ·  Feb 28 05:39
Summary by Futu AI
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.